Literature DB >> 25370682

Initial results of the National Colorectal Cancer Screening Program in Lithuania.

Tomas Poskus1, Kestutis Strupas, Saulius Mikalauskas, Dominyka Bitinaitė, Augustas Kavaliauskas, Narimantas E Samalavicius, Zilvinas Saladzinskas.   

Abstract

The aim of the present study was to review the National Colorectal Cancer Screening Program (the Program) in Lithuania according to the criteria set by the European Union. In Lithuania, screening services are provided free of charge to the population. The National Health Insurance Fund (NHIF) reimburses the institutions for performing each service; each procedure within the Program has its own administrative code. All the information about the performance of the Program is collected in one institution - the NHIF. The results of the Program were retrieved from the database of NHIF from the start of the Program from 1 July 2009 to 1 July 2012. Descriptive analysis of epidemiological indicators was carried out. Results were compared with the references in the guidelines of the European Union for quality assurance in colorectal cancer (CRC) screening and diagnosis. Information service [which involves fecal immunochemical test (FIT)] was provided to 271,396 of 890,309 50-74-year-old residents. The screening uptake was 46.0% over 3 years. During this period, 19,455 (7.2%) FITs were positive and 251,941 (92.8%) FITs were negative. Referral for colonoscopy was performed in 10,190 (52.4%) patients. Colonoscopy was performed in 12,864 (66.1%) patients. Colonoscopy did not indicate any pathological findings in 8613 (67.0%) patients. Biopsies were performed in 4251 (33.0%) patients. The rate of high-grade neoplasia reported by pathologists was 3.9%; the rate of cancer was 3.1% of all colonoscopies. The rate of CRC detected by the Program was 0.2%. The CRC screening program in Lithuania meets most of the requirements for standardized CRC screening programs. The invitation coverage and rate of referral for colonoscopy after positive FIT should be improved.

Entities:  

Mesh:

Year:  2015        PMID: 25370682     DOI: 10.1097/CEJ.0000000000000096

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  5 in total

1.  Improved perioperative care is associated with improved long-term survival in colorectal cancer.

Authors:  Eligijus Poskus; Marius Kryzauskas; Tomas Poskus; Saulius Mikalauskas; Narimantas Evaldas Samalavicius; Oleg Aliosin; Sarunas Dailidenas; Algimantas Tamelis; Zilvinas Saladzinskas; Paulius Lizdenis; Audrone Jakaitiene; Giedre Smailyte; Kestutis Strupas
Journal:  Int J Colorectal Dis       Date:  2018-03-12       Impact factor: 2.571

2.  Predictors of Quality of Life Six Years after Curative Colorectal Cancer Surgery: Results of the Prospective Multicenter Study.

Authors:  Gintare Valeikaite-Tauginiene; Agne Kraujelyte; Eligijus Poskus; Valdemaras Jotautas; Zilvinas Saladzinskas; Algimantas Tamelis; Paulius Lizdenis; Audrius Dulskas; Narimantas Evaldas Samalavicius; Kęstutis Strupas; Tomas Poškus
Journal:  Medicina (Kaunas)       Date:  2022-03-26       Impact factor: 2.948

Review 3.  Colorectal cancer population screening programs worldwide in 2016: An update.

Authors:  Mercedes Navarro; Andrea Nicolas; Angel Ferrandez; Angel Lanas
Journal:  World J Gastroenterol       Date:  2017-05-28       Impact factor: 5.742

4.  Perceived Deterrence Towards Colonoscopy for Colorectal Cancer Screening among Northern Malaysia Population: A Qualitative Study.

Authors:  Mohd Azri Mohd Suan; Wei Leong Tan; Ibtisam Ismail; Muhammad Radzi Abu Hassan
Journal:  Asian Pac J Cancer Prev       Date:  2020-05-01

5.  Colorectal Cancer Screening with Computed Tomography Colonography: Single Region Experience in Kazakhstan.

Authors:  Jandos Amankulov; Dilyara Kaidarova; Zhamilya Zholdybay; Marianna Zagurovskaya; Nurlan Baltabekov; Madina Gabdullina; Akmaral Ainakulova; Dias Toleshbayev; Alexandra Panina; Elvira Satbayeva; Zhansaya Kalieva
Journal:  Clin Endosc       Date:  2021-07-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.